Acasti Pharma Inc (ACST)
2.89
+0.11
(+3.96%)
USD |
NASDAQ |
May 01, 16:00
2.70
-0.19
(-6.57%)
After-Hours: 20:00
Acasti Pharma Free Cash Flow: -13.57M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.57M |
| September 30, 2023 | -15.40M |
| June 30, 2023 | -16.73M |
| March 31, 2023 | -15.93M |
| December 31, 2022 | -15.74M |
| September 30, 2022 | -16.60M |
| June 30, 2022 | -19.27M |
| March 31, 2022 | -17.23M |
| December 31, 2021 | -15.85M |
| September 30, 2021 | -15.48M |
| June 30, 2021 | -13.58M |
| March 31, 2021 | -14.39M |
| December 31, 2020 | -15.56M |
| September 30, 2020 | -18.71M |
| June 30, 2020 | -20.63M |
| March 31, 2020 | -23.27M |
| December 31, 2019 | -28.87M |
| September 30, 2019 | -28.45M |
| June 30, 2019 | -27.67M |
| March 31, 2019 | -25.32M |
| December 31, 2018 | -20.09M |
| September 30, 2018 | -16.76M |
| June 30, 2018 | -13.21M |
| March 31, 2018 | -10.05M |
| December 31, 2017 | -8.542M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.036M |
| June 30, 2017 | -6.219M |
| November 30, 2016 | -6.121M |
| August 31, 2016 | -5.612M |
| May 31, 2016 | -6.224M |
| February 29, 2016 | -5.123M |
| November 30, 2015 | -5.642M |
| August 31, 2015 | -6.206M |
| May 31, 2015 | -6.232M |
| February 28, 2015 | -5.822M |
| November 30, 2014 | -8.264M |
| August 31, 2014 | -7.267M |
| May 31, 2014 | -5.786M |
| February 28, 2014 | -6.249M |
| November 30, 2013 | -1.990M |
| August 31, 2013 | -1.729M |
| May 31, 2013 | -2.891M |
| February 28, 2013 | -2.590M |
| November 30, 2012 | -4.079M |
| August 31, 2012 | -6.63M |
| May 31, 2012 | -5.854M |
| February 29, 2012 | -5.648M |
| November 30, 2011 | -4.518M |
| August 31, 2011 | -2.62M |
| May 31, 2011 | -2.225M |
Free Cash Flow Range, Past 5 Years
-28.87M
Minimum
Dec 2019
-13.57M
Maximum
Dec 2023
-18.57M
Average
-16.60M
Median
Sep 2022
Free Cash Flow Benchmarks
| Aurinia Pharmaceuticals Inc | -34.18M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.408M |
| Xenon Pharmaceuticals Inc | -150.94M |
| ESSA Pharma Inc | -22.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.892M |
| Cash from Investing (Quarterly) | -6.554M |
| Free Cash Flow Per Share (Quarterly) | -0.0424 |
| Free Cash Flow Yield | -17.92% |